CD5+ B cells with the features of subepithelial B cells found in human tonsils

European Journal of Immunology

Volumn 37, Issue 8, 2007, Pages 2138-2147

  Dono, Mariella ^a   Burgio, Vito Lelio ^b   Colombo, Monica ^a   Sciacchitano, Salvatore ^b   Reverberi, Daniele ^a   Tarantino, Vincenzo ^e   Cutrona, Giovanna ^a   Chiorazzi, Nicholas ^c   Ferrarini, Manlio ^a,d  

^a UNIVERSITY OF GENOA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^d UNIVERSITY OF GENOA   (Italy)

^e G GASLINI INSTITUTE   (Italy)

Author keywords

B cells; Marginal zone; Tonsil

Indexed keywords

CD23 ANTIGEN; IMMUNOGLOBULIN D; IMMUNOGLOBULIN M;

ARTICLE; B LYMPHOCYTE; CD5+ B LYMPHOCYTE; CELL ISOLATION; CONTROLLED STUDY; EPITHELIUM CELL; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN VARIABLE REGION; IN VIVO STUDY; LYMPHOCYTE SUBPOPULATION; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; SPLEEN CELL; TONSIL; UNINDEXED SEQUENCE;

ADOLESCENT; ANTIGENS, CD5; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENES, IMMUNOGLOBULIN; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE SUBSETS; MUTATION; POLYMERASE CHAIN REACTION; TONSIL;

EID: 34547903876     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200636887     Document Type: Article

References (39)

1. Dono, M., Burgio, V. L., Tacchetti, C., Favre, A., Augliera, A., Zupo, S., Taborelli, G. et al., Subepithelial B cells in the human Palatine tonsil. I. Morphologic, cytochemical and phenotypic characterization. Eur. J. Immunol. 1996. 26: 2035-2042.
2. Dono, M., Zupo, S., Leanza, N., Melioli, G., Fogli, M., Melagrana, A., Chiorazzi, N. and Ferrarini, M., Heterogeneity of tonsillar subepithelial B lymphocytes, the splenic marginal zone equivalents. J. Immunol. 2000. 164: 5596-5604.
3. Fischer, M., Klein, U. and Kuppers, R., Molecular single-cell analysis reveals that CD5-positive peripheral blood B cells in healthy humans are characterized by rearranged Vkappa genes lacking somatic mutation. J. Clin. Invest. 1997. 100: 1667-1676.
4. Spencer, J., Perry, M. E. and Dunn-Walters, D. K., Human marginal-zone B cells. Immunol. Today 1998. 19: 421-426.
5. Zandvoort, A. and Timens, W., The dual function of the splenic marginal zone: Essential for initiation of anti-TI-2 respon but also vital in the general first-line defense against blood-borne antigens. Clin. Exp. Immunol. 2002. 130: 4-11.
6. Herve, M., Ku, K., Ng, Y. S., Wardemann, H., Albesiano, E., Messmer, B. T., Chiorazzi N. and Meffre, E., Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity. J. Clin. Invest. 2005. 115: 1636-1643.
7. Hardy, R. R., B-1 B cell development. J. Immunol. 2006. 177: 2749-2754.
8. Hardy, R. R. and Hayakawa, K., B cell development pathways. Annu. Rev. Immunol. 2001. 19: 595-621.
9. Liu, Y. J., Johnson, G. D., Gordon, J. and MacLennan, I. C., Germinal centres in T-cell-dependent antibody responses. Immunol. Today 1992. 13: 17-21.
10. Dono, M., Zupo, S., Augliera, A., Burgio, V. L., Massara, R., Metagrana, A., Costa, M. et al., Subepithelial B cells in the human palatine tonsil. II. Functional characterization. Eur. J. Immunol. 1996. 26: 2043-2049.
11. Martin, F. and Kearney, J. F., B1 cells: Similarities and differences with other B cell subsets. Curr. Opin. Immunol. 2001. 13: 195-201.
12. Brezinschek, H. P., Foster, S. J., Brezinschek, R. I., Dorner, T., Domiati-Saad, R. and Lipsky, P. E., Analysis of the human VH gene repertoire. Differential effects of selection and somatic hypermutation on human peripheral CDS(+)/IgM+ and CD5(-)IgM+ B cells. J. Clin. Invest. 1997. 99: 2488-2501.
13. + B cells and helper T cells in immunoglobulin production. Eur. J. Immunol. 1997. 27: 2073-2079.
14. + peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J. Exp. Med. 1998. 188: 1679-1689.
15. + B lymphocyte subset. J. Immunol. 1992. 148: 3700-3705.
16. Mond, J. J., Lees, A. and Snapper, C. M., T cell-independent antigens type 2. Annu. Rev. Immunol. 1995. 13: 655-692.
17. Subbarao, B. and Mosier, D. E., Lyb antigens and their role in B lymphocyte activation. Immunol. Rev. 1982. 69: 81-97.
18. Weller, S., Braun, M. C., Tan, B. K., Rosenwald, A., Cordier, C., Conley, M. E., Plebani, A. et al., Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 2004. 104: 3647-3654.
19. Arpin, C., de Bouteiller, O., Razanajaona, D., Fugier-Vivier, I., Briere, F., Banchereau, J., Lebecque, S. and Liu, Y. J., The normal counterpart of IgD myeloma cells in germinal center displays extensively mutated IgVH gene, Cmu-Cdelta switch, and lambda light chain expression. J. Exp. Med. 1998. 187: 1169-1178.
20. Zupo, S., Donn, M., Massara, R., Taborelli, G., Chiorazzi, N. and Ferrarini, M., Expression of CD5 and CD38 by human CD5- B cells: requirement for special stimuli. Eur. J. Immunol. 1994. 24: 1426-1433.
21. Hillion, S., Saraux, A., Youinou, P. and Jamin, C., Expression of RAGs in peripheral B cells outside germinal centers is associated with the expression of CD5. J. Immunol. 2005. 174: 5553-5561.
22. Timens, W., Boes, A. and Poppema, S., Human marginal zone B cells are not an activated B cell subset: Strong expression of CD21 as a putative mediator for rapid B cell activation. Eur. J. Immunol. 1989. 19: 2163-2166.
23. Timens, W. and Poppema, S., Lymphocyte compartments in human spleen. An immunohistologic study in normal spleens and uninvolved spleens in Hodgkin's disease. Am. J. Pathol. 1985. 120: 443-454.
24. Damle, R. N., Ghiotto, F., Valetto, A., Albesiano, E., Fats, F., Yan, X. J., Sison, C. P. et al., B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. Blood. 2002. 99: 4087-4093.
25. Chiomzzi, N. and Ferrarini, M., B cell chronic lymphocytic leukemia: Lessons learned from studies of the B cell antigen receptor. Annu. Rev. Immunol. 2003. 21: 841-894.
26. Kuppers, R., Zhao, M., Hansmann, M. L. and Rojewsky, K., Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. EMBO J. 1993. 12: 4955-4967.
27. Pascual, V., Liu, Y. J., Magalski, A., de Bouteiller, O, Banchereau, J. and Capra, J. D., Analysis of somatic mutation in five B cell subsets of human tonsil. J. Exp. Med. 1994. 180: 329-339.
28. Macpherson, A. J., Lamarre, A., McCoy, K., Harriman, G. R., Odermatt, B., Dougan, G., Hengartner, H. and Zinkernagel, R. M., IgA production without mu or delta chain expression in developing B cells. Nat. Immunol. 2001. 2: 625-631.
29. Dorshkind, K. and Montecino-Rodriguez, E., Fetal B-cell lymphopoiesis and the emergence of B-1-cell potential. Nat Rev. Immunol. 20O7: 7: 213-219.
30. Caligaris-Cappio, F. and Ghia, P., The nature and origin of the B-chronic lymphocytic leukemia cell: A tentative model. Hematol. Oncol. Clin North Am. 2004. 18: 849-862, viii.
31. Xiao, Y., Hendriks, J., Langerak P., Jacobs, H. and Rom J., CD27 is acquired by primed B cells at the centroblast stage and promotes germinal center formation. J. Immunol. 2004. 172: 7432-7441.
32. Weller, S., Faili A., Garcia, C., Braun, M. C., Le Deist, F. F., de Saint Basile, G. G., Hermine, O. et al., CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. Proc. Natl. Acad. Sci. USA 2001. 98: 1166-1170.
33. William, J., Euler, C., Christensen, S. and Shlomchik, M. J., Evolution of autoantibody responses via somatic hypermutation outside of germinal centers. Science 2002. 297: 2066-2070.
34. Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y. and Honjo, T., Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000. 102: 553-563.
35. Revy, P., Muto, T., Levy, Y., Geissmann, F., Plebani, A., Sanal, O., Catalan, N. et al., Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 2000. 102: 565-575.
36. Willenbrock, K., Jungnickel, B., Hansmann, M. I. and Kuppers, R., Human splenic marginal zone B cells lack expression of activation-induced cytidine deaminase. Eur. J. Immunol. 2005. 35: 3002-3007.
37. Weller, S., Reynaud, C. A. and Weill, J. C., Splenic marginal zone B cells in humans: Where do they mutate their Ig receptor? Eur. J. Immunol. 2005. 35: 2789-2792.
38. Cattoretti, G., Buttner, M., Shalmovich, R., Kremmer, E., Alobeid, B. and Niedobitek, G., Nuclear and cytoplasmic AID in extrafollicular and germinal center B cells. Blood 2006. 107: 3967-3975.
39. Zheng L., Cui, X., Schmitt, K., Hubert, R., Navidi, W. and Arnheim, N., Whole genome amplification from a single cell: implications for genetic analysis. Proc. Natl. Acad Sd USA 1992. 89: 5847-5851.